Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease

New England Journal of Medicine

Volumn 349, Issue 19, 2003, Pages 1812-1820

  Glatzel, Markus ^b   Abela, Eugenio ^b   Maissen, Manuela ^b   Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTUNGSTIC ACID; PRION PROTEIN; SODIUM PHOSPHOTUNGSTIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; OLFACTORY NERVE; PATHOGENESIS; PRECIPITATION; PRION DISEASE; PRIORITY JOURNAL; SPLEEN; WESTERN BLOTTING; BRAIN; GENETICS; METABOLISM; PATHOLOGY; PRION; SKELETAL MUSCLE;

BLOTTING, WESTERN; BRAIN; CREUTZFELDT-JAKOB SYNDROME; HUMANS; MUSCLE, SKELETAL; PRIONS; PRPSC PROTEINS; SPLEEN;

EID: 0242361687     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa030351     Document Type: Article

References (30)

1. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998;95:13363-83.
2. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983;35:349-58.
3. Aguzzi A, Montrasio F, Kaeser PS. Prions: health scare and biological challenge. Nat Rev Mol Cell Biol 2001;2:118-26.
4. Bosque PJ, Ryou C, Telling G, et al. Prions in skeletal muscle. Proc Natl Acad Sci U S A 2002;99:3812-7.
5. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
6. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-50, 526.
7. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
8. Wadsworth JDF, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80.
9. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
10. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
11. Safar J, Wille H, Itri V, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-65.
12. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987;61:3688-93.
13. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002;360:139-41.
14. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-78.
15. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-90.
16. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AK, Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999;1:55-9.
17. Windl O, Giese A, Schulz-Schaeffer W, et al. Molecular genetics of human prion diseases in Germany. Hum Genet 1999;105:244-52.
18. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
19. Blättler T, Brandner S, Raeber AJ, et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997;389:69-73.
20. Nakamura Y, Yanagawa H, Kitamoto T, Sato T. Epidemiologic features of 65 Creutzfeldt-Jakob disease patients with a history of cadaveric dura mater transplantation in Japan. Epidemiol Infect 2000;125:201-5.
21. Joiner S, Linehan J, Brandner S, Wadsworth JD, Collinge J. Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002;73:597-8.
22. Klein MA, Kaeser PS, Schwarz P, et al. Complement facilitates early prion pathogenesis. Nat Med 2001;7:488-92.
23. Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport 1993;5:25-8.
24. Zanusso G, Vattemi G, Ferrari S, et al. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol 2001;11:182-9.
25. Hill AF, Joiner S, Wadsworth JD, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003;126:1333-46.
26. Rossetti AO, Glatzel M, Aguzzi A, Janzer R, Bogousslavsky J. Clinical and radiological mimicry of vCJD in a valine homozygous PrP(Sc) type 1 sCJD patient. J Neurol 2003;250:491-3.
27. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29.
28. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-7.
29. Aguzzi A. Prion diseases, blood and the immune system: concerns and reality. Haematologica 2000;85:3-10.
30. Aguzzi A, Heikenwalder M. Prion diseases: cannibals and garbage piles. Nature 2003;423:127-9.